Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 140462-76-6 Chemical Structure| 140462-76-6

Structure of Olopatadine HCl
CAS No.: 140462-76-6

Chemical Structure| 140462-76-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Olopatadine HCl can block the release of histamine (IC50 = 559 µM) and stabilize mast cell.

Synonyms: KW4679; ALO4943A; Patanase

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Olopatadine HCl

CAS No. :140462-76-6
Formula : C21H24ClNO3
M.W : 373.87
SMILES Code : O=C(O)CC1=CC=C(C/2=C1)OCC3=CC=CC=C3C2=C\CCN(C)C.[H]Cl
Synonyms :
KW4679; ALO4943A; Patanase
MDL No. :MFCD00875716
InChI Key :HVRLZEKDTUEKQH-NOILCQHBSA-N
Pubchem ID :5282402

Safety of Olopatadine HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H400
Precautionary Statements:P264-P270-P273-P301+P310+P330-P391-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Olopatadine HCl

GPCR

Isoform Comparison

Biological Activity

Target
  • Histamine receptor

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02709538 Perennial Allergic Rhinitis Phase 3 Completed - -
NCT02709538 - Completed - -
NCT03464435 Vernal Keratoconjunctivitis Phase 4 Completed - -
NCT02478398 Rhinitis, Allergic, Seasonal Phase 3 Completed - -
NCT03320434 Allergic Conjunctivitis Phase 2 Completed - United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less <<
NCT01700192 Rhinitis, Allergic, Perennial ... More >> Rhinitis, Allergic, Nonseasonal Less << Phase 3 Completed - -
NCT00550550 Rhinoconjunctivitis ... More >> Rhinitis Conjunctivitis Allergy Less << Phase 3 Completed - -
NCT01700192 - Completed - -
NCT00562159 Rhinoconjunctivitis ... More >> Rhinitis Conjunctivitis Allergy Less << Phase 3 Completed - -
NCT00562159 - Completed - -
NCT03463031 Seasonal Allergic Rhinitis (SA... More >>R) Less << Phase 3 Recruiting September 30, 2018 -
NCT02318303 Seasonal Allergic Rhinitis Phase 2 Completed - United States, Texas ... More >> Glenmark Investigational Site 10 Austin, Texas, United States Glenmark Investigational Site 5 Austin, Texas, United States Glenmark Investigational Site 6 Austin, Texas, United States Glenmark Investigational Site 2 Kerrville, Texas, United States Glenmark Investigational Site 7 New Braunfels, Texas, United States Glenmark Investigational Site 3 San Antonio, Texas, United States Glenmark Investigational Site 4 San Antonio, Texas, United States Glenmark Investigational Site 8 San Antonio, Texas, United States Glenmark Investigational Site 9 San Antonio, Texas, United States Glenmark Investigational Site 1 Waco, Texas, United States Less <<
NCT00550550 - Completed - -
NCT02318303 - Completed - -
NCT02631551 - Completed - -
NCT02631551 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT02870205 - Completed - -
NCT00845195 Seasonal Allergic Rhinitis Phase 4 Completed - United States, Texas ... More >> Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT02870205 Seasonal Allergic Rhinitis (SA... More >>R) Less << Phase 3 Completed - -
NCT00534794 Allergic Conjunctivitis Phase 4 Completed - United States, Massachusetts ... More >> Ophthalmic Consultants of Boston Boston, Massachusetts, United States, 02114 Less <<
NCT01495338 Normal Ocular Health Phase 1 Completed - United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less <<
NCT00534794 - Completed - -
NCT01282138 Allergic Conjunctivitis Phase 4 Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01363700 - Completed - -
NCT00845195 - Completed - -
NCT01470118 Conjunctivitis, Allergic Phase 4 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States Less <<
NCT01363700 Allergic Conjunctivitis Phase 3 Completed - Japan ... More >> Santen study sites Osaka, Japan Less <<
NCT01470118 - Completed - -
NCT00979615 Vasomotor Rhinitis Phase 4 Completed - United States, Texas ... More >> Contact Alcon Call Center For Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00979615 - Completed - -
NCT01282138 - Completed - -
NCT00489398 Allergic Conjunctivitis Phase 4 Withdrawn(Protocol changes) December 2008 -
NCT01294969 Allergic Conjunctivitis Phase 4 Completed - Korea, Republic of ... More >> Alcon Korea Ltd. Seoul, Korea, Republic of, 06181 Less <<
NCT01698814 - Completed - -
NCT00772304 - Completed - -
NCT01698814 Allergic Conjunctivitis Phase 3 Completed - -
NCT00818805 Allergic Conjunctivitis Phase 4 Completed - -
NCT00772304 Allergic Rhinitis Phase 4 Completed - United States, Texas ... More >> Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00818805 - Completed - -
NCT01007253 - Completed - -
NCT02161146 - Completed - -
NCT01007253 Seasonal Allergic Rhinitis Phase 4 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00836485 Allergic Conjunctivitis Phase 2 Completed - United States, Massachusetts ... More >> Ora Andover, Massachusetts, United States, 01810 Less <<
NCT01076439 Allergic Rhinitis Phase 4 Withdrawn - -
NCT01732757 Conjunctivitis, Allergic Phase 4 Completed - United States, Tennessee ... More >> Memphis, Tennessee, United States Less <<
NCT02161146 Conjunctivitis, Allergic Phase 3 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00389025 Allergic Conjunctivitis Phase 4 Completed - Italy ... More >> Padova Site Padova, Italy Less <<
NCT01732757 - Completed - -
NCT01743027 - Completed - -
NCT00691665 Seasonal Allergic Rhinitis Phase 4 Completed - United States, California ... More >> Sacramento, CA Sacramento, California, United States, 95819 Less <<
NCT00655109 Conjunctivitis, Allergic Phase 4 Completed - United States, Massachusetts ... More >> Ophthalmic Research Associates, Inc North Andover, Massachusetts, United States, 01845 Less <<
NCT00578331 Perennial Allergic Rhinitis Phase 3 Completed - United States, Texas ... More >> Waco Waco, Texas, United States, 76712 Less <<
NCT00578331 - Completed - -
NCT00691665 - Completed - -
NCT00578929 Seasonal Allergic Rhinitis Phase 3 Completed - United States, Illinois ... More >> Kenilworth/IL Kenilworth, Illinois, United States, 60043 Less <<
NCT00609128 Allergic Conjunctivitis Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT01743027 Allergic Conjunctivitis Phase 3 Completed - -
NCT01287338 Seasonal Allergic Conjunctivit... More >>is to Ragweed Less << Phase 2 Terminated(Lack of definitive ... More >>clinical results.) Less << - Canada, Ontario ... More >> Cetero Research Toronto, Ontario, Canada Less <<
NCT01159769 Allergic Conjunctivitis Phase 4 Completed - -
NCT00794144 Allergic Rhinitis Phase 2 Completed - United States, Texas ... More >> Niran Amar, M.D. Waco, Texas, United States, 76712 Less <<
NCT00609128 - Completed - -
NCT01159769 - Completed - -
NCT00578929 - Completed - -
NCT00794144 - Completed - -
NCT01344083 Seasonal Allergic Conjunctivit... More >>is Less << Phase 2 Completed - France ... More >> Pierre Huguet Clermont ferrand, France, 63000 Less <<
NCT03444506 Seasonal Allergic Rhinitis Phase 2 Completed - Canada, Ontario ... More >> Glenmark Investigational Site 1 Mississauga, Ontario, Canada, L4W 1V7 Less <<
NCT00331500 Allergic Conjunctivitis Phase 3 Completed - -
NCT01119287 Allergic Conjunctivitis Phase 4 Completed - United States, Texas ... More >> Contact Alcon Call Center For Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01109485 Allergic Conjunctivitis Phase 4 Completed - Japan ... More >> Contact Alcon Call Center For Trial Locations Tokyo, Japan, 1F Less <<
NCT01697969 - Completed - -
NCT01697969 Allergic Conjunctivitis Phase 4 Completed - United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52242-1091 Less <<
NCT01119287 - Completed - -
NCT01479374 - Completed - -
NCT02251613 Allergic Conjunctivitis Phase 4 Completed - -
NCT01479374 Allergic Conjunctivitis Phase 3 Completed - -
NCT00789555 Perennial Allergic Rhinitis Phase 4 Completed - United States, Texas ... More >> Contact Alcon Call Center For Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00987272 Allergic Conjunctivitis Phase 3 Completed - -
NCT00789555 - Completed - -
NCT00775658 Allergic Rhinitis ... More >> Allergic Conjunctivitis Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt Asthma, Sinus and Allergy Program Research Nashville, Tennessee, United States, 37203 Less <<
NCT00775658 - Completed - -
NCT02251613 - Completed - -
NCT01435460 Seasonal Allergic Conjunctivit... More >>is Less << Phase 3 Completed - Singapore ... More >> Bausch & Lomb Singapore Singapore, Singapore, 556741 Less <<
NCT01435460 - Completed - -
NCT01258309 Rhinitis, Allergic, Seasonal ... More >> Conjunctivitis, Allergic Less << Phase 3 Completed - India ... More >> Bangalore, Karnataka, India Less <<
NCT01450176 Eye Allergies Not Applicable Completed - United States, Tennessee ... More >> McCabe Vision Center Murfreesboro, Tennessee, United States, 37129 Less <<
NCT01037179 Allergic Conjunctivitis Phase 3 Completed - Japan ... More >> Investigational Center Osaka-shi, Osaka, Japan, 532-0003 Less <<
NCT01326858 Allergic Conjunctivitis Phase 1 Completed - -
NCT01657240 Allergic Conjunctivitis Phase 3 Withdrawn(Formula Reformulatio... More >>n) Less << May 2015 -
NCT01272089 Allergic Conjunctivitis Phase 4 Completed - India ... More >> Kolkata, India, 700020 Less <<
NCT02322216 Allergic Conjunctivitis Phase 3 Completed - -
NCT03186755 Conjunctivitis, Allergic ... More >> Conjunctivitis, Vernal Less << Phase 4 Recruiting December 2019 Canada, Quebec ... More >> CHU Sainte-Justine Hospital Recruiting Montréal, Quebec, Canada, H3T 1C5 Contact: Michael Marchand, MD    514-805-1247    mic9@sympatico.ca    Principal Investigator: Emilie Goodyear, MD          Sub-Investigator: Michael Marchand, MD Less <<
NCT02322216 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.67mL

0.53mL

0.27mL

13.37mL

2.67mL

1.34mL

26.75mL

5.35mL

2.67mL

References

 

Historical Records

Categories